<?properties open_access?>
<?properties manuscript?>
<?origin nihpa?>
<?iso-abbr Nat. Methods?>
<?submitter-system nihms?>
<?submitter-canonical-name Nature Publishing Group?>
<?submitter-canonical-id NATURE-STRUCTUR?>
<?submitter-userid 8068858?>
<?submitter-authority myNCBI?>
<?submitter-login nature-structure?>
<?submitter-name Nature Publishing Group?>
<?domain nihpa?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-journal-id">101215604</journal-id>
    <journal-id journal-id-type="pubmed-jr-id">32338</journal-id>
    <journal-id journal-id-type="nlm-ta">Nat Methods</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nat. Methods</journal-id>
    <journal-title-group>
      <journal-title>Nature methods</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1548-7091</issn>
    <issn pub-type="epub">1548-7105</issn>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6026581</article-id>
    <article-id pub-id-type="pmid">29355848</article-id>
    <article-id pub-id-type="doi">10.1038/nmeth.4540</article-id>
    <article-id pub-id-type="manuscript">nihpa925038</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Interactome INSIDER: a structural interactome browser for genomic
studies</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Meyer</surname>
          <given-names>Michael J.</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
        <xref ref-type="aff" rid="A2">2</xref>
        <xref ref-type="aff" rid="A3">3</xref>
        <xref rid="FN2" ref-type="author-notes">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Beltrán</surname>
          <given-names>Juan Felipe</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
        <xref ref-type="aff" rid="A2">2</xref>
        <xref rid="FN2" ref-type="author-notes">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liang</surname>
          <given-names>Siqi</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
        <xref ref-type="aff" rid="A2">2</xref>
        <xref rid="FN2" ref-type="author-notes">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Fragoza</surname>
          <given-names>Robert</given-names>
        </name>
        <xref ref-type="aff" rid="A2">2</xref>
        <xref ref-type="aff" rid="A4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Rumack</surname>
          <given-names>Aaron</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
        <xref ref-type="aff" rid="A2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liang</surname>
          <given-names>Jin</given-names>
        </name>
        <xref ref-type="aff" rid="A2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wei</surname>
          <given-names>Xiaomu</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
        <xref ref-type="aff" rid="A5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Haiyuan</given-names>
        </name>
        <xref ref-type="aff" rid="A1">1</xref>
        <xref ref-type="aff" rid="A2">2</xref>
        <xref rid="FN1" ref-type="author-notes">*</xref>
      </contrib>
    </contrib-group>
    <aff id="A1"><label>1</label>Department of Biological Statistics and Computational Biology, Cornell
University, Ithaca, New York, 14853, USA</aff>
    <aff id="A2"><label>2</label>Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca,
New York, 14853, USA</aff>
    <aff id="A3"><label>3</label>Tri-Institutional Training Program in Computational Biology and Medicine,
New York, New York, 10065, USA</aff>
    <aff id="A4"><label>4</label>Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY
14853, USA</aff>
    <aff id="A5"><label>5</label>Department of Medicine, Weill Cornell College of Medicine, New York, New
York, 10065, USA</aff>
    <author-notes>
      <corresp id="FN1"><label>*</label>To whom correspondence should be addressed. Tel: 607-255-0259;
Fax: 607-255-5961; <email>haiyuan.yu@cornell.edu</email></corresp>
      <fn id="FN2">
        <label>†</label>
        <p>The authors wish it to be known that, in their opinion, the first 3 authors should be
regarded as joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="nihms-submitted">
      <day>6</day>
      <month>12</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>01</day>
      <month>1</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <month>2</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>12</day>
      <month>7</month>
      <year>2018</year>
    </pub-date>
    <volume>15</volume>
    <issue>2</issue>
    <fpage>107</fpage>
    <lpage>114</lpage>
    <!--elocation-id from pubmed: 10.1038/nmeth.4540-->
    <permissions>
      <license>
        <license-p>Users may view, print, copy, and download text and data-mine the content in
such documents, for the purposes of academic research, subject always to the full
Conditions of use: <uri xlink:type="simple" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
      </license>
    </permissions>
    <abstract>
      <p id="P1">We present Interactome INSIDER, a tool to link genomic variant information with
structural protein-protein interactomes. Underlying this tool is the application of
machine learning to predict protein interaction interfaces for 185,957 protein
interactions with previously unresolved interfaces, in human and 7 model organisms,
including the entire experimentally determined human binary interactome. Predicted
interfaces exhibit similar functional properties as known interfaces, including enrichment
for disease mutations and recurrent cancer mutations. Through 2,164 <italic>de
novo</italic> mutagenesis experiments, we show that mutations of predicted and known
interface residues disrupt interactions at a similar rate, and much more frequently than
mutations outside of predicted interfaces. To spur functional genomic studies, Interactome
INSIDER (<ext-link ext-link-type="uri" xlink:href="http://interactomeinsider.yulab.org">http://interactomeinsider.yulab.org</ext-link>) enables users to identify whether
variants or disease mutations are enriched in known and predicted interaction interfaces
at various resolutions. Users may explore known population variants, disease mutations,
and somatic cancer mutations, or upload their own set of mutations for this purpose.</p>
    </abstract>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="S1">
    <title>INTRODUCTION</title>
    <p id="P2">Protein-protein interactions facilitate much of known cellular function. Recent
efforts to experimentally determine protein interactomes in human<sup><xref rid="R1" ref-type="bibr">1</xref></sup> and model organisms<sup><xref rid="R2" ref-type="bibr">2</xref>–<xref rid="R4" ref-type="bibr">4</xref></sup>, in addition to
literature curation of small-scale interaction assays<sup><xref rid="R5" ref-type="bibr">5</xref></sup>, have dramatically increased the scale of known interactome networks.
Studies of these interactomes have allowed researchers to elucidate how modes of evolution
affect the functional fates of paralogs<sup><xref rid="R4" ref-type="bibr">4</xref></sup>
and to examine, on a genomic scale, network interconnectivities that determine cellular
functions and disease states<sup><xref rid="R6" ref-type="bibr">6</xref></sup>.</p>
    <p id="P3">While simply knowing which proteins interact with each other provides valuable
information to spur functional studies, far more specific hypotheses can be tested if the
spatial contacts of interacting proteins are known<sup><xref rid="R7" ref-type="bibr">7</xref></sup>. In the study of human disease, it has been demonstrated that mutations
tend to localize to interaction interfaces and mutations on the same protein may cause
clinically distinct diseases by disrupting interactions with different partners<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup>.
However, the binding topologies of interacting proteins can only be determined at atomic
resolution through X-ray crystallography, NMR, and more recently cryo-EM<sup><xref rid="R9" ref-type="bibr">9</xref></sup> experiments, limiting the number of interactions with
resolved interaction interfaces.</p>
    <p id="P4">To study protein function on a genomic scale, especially as it relates to human
disease, a large-scale set of protein interaction interfaces is needed. Thus far,
computational methods, such as docking<sup><xref rid="R10" ref-type="bibr">10</xref></sup>
and homology modeling<sup><xref rid="R11" ref-type="bibr">11</xref></sup>, have been
employed to predict the atomic-level bound conformations of interactions whose experimental
structures have not yet been determined. However, But docked models are not yet available on
a large scale, and while homology modeling has been used to produce models at
scale<sup><xref rid="R12" ref-type="bibr">12</xref></sup>, it is only amenable to
interactions with structural templates (&lt;5% of known interactions). Together,
co-crystal structures and homology models comprise the currently available pre-calculated
sources of structural interactomes, covering only ~6% of all known interactions
(<xref rid="F1" ref-type="fig">Fig. 1a–b</xref>).</p>
    <p id="P5">Here, we present Interactome INSIDER
(<bold><underline>IN</underline></bold>tegrated
<bold><underline>S</underline></bold>tructural
<bold><underline>I</underline></bold>nteractome and genomic
<bold><underline>D</underline></bold>ata brows<bold><underline>ER</underline></bold>), a
tool for functional exploration of human disease on a genomic scale (<ext-link ext-link-type="uri" xlink:href="http://interactomeinsider.yulab.org">http://interactomeinsider.yulab.org</ext-link>). Interactome INSIDER is based on a
structurally-resolved, proteome-wide human interactome. We assembled this resource by
building an interactome-wide set of protein interaction interfaces at the highest resolution
possible for each interaction. We compiled structural interactomes by calculating interfaces
in experimental co-crystal structures and homology models, when available. For the remaining
~94% of interactions, we applied a machine learning framework to predict
partner-specific interfaces by applying recent advances in co-evolution- and docking-based
feature construction<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup>. Interactome INSIDER combines predicted interaction
interfaces for 185,957 previously un-resolved interactions (including the full human
interactome and 7 commonly studied model organisms) with disease mutations and functional
annotations in an interactive toolbox designed to spur functional genomics research. It
allows users to find enrichment of disease mutations at different scales: in protein
interaction domains, in residues, and through atomic 3D clustering in protein
interfaces.</p>
  </sec>
  <sec sec-type="results" id="S2">
    <title>RESULTS</title>
    <p id="P6">To build Interactome INSIDER, we first constructed an interactome-wide set of
protein interaction interfaces. While there are well-established methods for predicting
whether or not two proteins interact<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup>, we focused on interactions that have been
experimentally determined, but whose interfaces are unknown (<xref rid="SD1" ref-type="supplementary-material">Supplementary Note 1</xref>). For this task, there is a
rich literature exploring the potential of many structural, evolutionary, and docking-based
methods to predict protein interaction interfaces. However, so far, none of these methods
have been used to produce a whole-interactome dataset of protein interaction interfaces
(<xref rid="SD1" ref-type="supplementary-material">Supplementary Note 2</xref>).</p>
    <p id="P7">We used ECLAIR (<bold><underline>E</underline></bold>nsemble
<bold><underline>C</underline></bold>lassifier
<bold><underline>L</underline></bold>earning <bold><underline>A</underline></bold>lgorithm
to predict <bold><underline>I</underline></bold>nterface
<bold><underline>R</underline></bold>esidues), a unified machine learning framework, to
predict the interface of protein interactions. ECLAIR leverages several complementary and
proven classification features, including sequence-based biophysical features, structural
features, and recently proposed features for predicting binding partner-specific interfaces,
including co-evolutionary<sup><xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref></sup> and docking-based metrics<sup><xref rid="R14" ref-type="bibr">14</xref></sup> (<xref rid="SD1" ref-type="supplementary-material">Supplementary Note 3</xref>, <xref rid="SD3" ref-type="supplementary-material">Supplementary Figs. 1–2</xref>). Unfortunately, many protein-protein interactions
have missing features (especially structural features). In fact, this type of non-random
missing-feature problem is present in many biological prediction studies, and cannot be
adequately resolved by commonly-used imputation methods. To address this issue, ECLAIR is
structured as an ensemble of 8 independent classifiers, each covering a common case of
feature availability. This unique structure of ECLAIR enables it to be applied to any
interaction, while using the most informative subset of available features for that
interaction (<xref rid="SD1" ref-type="supplementary-material">Supplementary Note
4–5</xref>, <xref rid="SD3" ref-type="supplementary-material">Supplementary Figs.
3–4</xref>).</p>
    <p id="P8">We comprehensively optimized hyperparameters for ECLAIR using a recently published
Bayesian method, the tree-structured Parzen estimator approach (TPE)<sup><xref rid="R19" ref-type="bibr">19</xref></sup>, which allowed us to simultaneously tune up to 8
hyperparameters for each sub-classifier (<xref rid="SD1" ref-type="supplementary-material">Supplementary Note 4</xref>). We trained and tested each ECLAIR sub-classifier using a
set of known protein interaction interfaces, and observed that interfaces can be predicted
by the single, top-performing sub-classifier available for each residue (<xref rid="SD1" ref-type="supplementary-material">Supplementary Note 4</xref>, <xref rid="SD3" ref-type="supplementary-material">Supplementary Fig. 5</xref>). Sub-classifier performance
increases with the number of features used. We observe an area under the ROC curve (AUROC)
of 0.64 for our top sequence-only sub-classifier and AUROC of 0.80 for our top
sub-classifier using both sequence and structural features. In total, we used ECLAIR to
predict the interfaces of 185,957 interactions with previously unknown interfaces, including
for 115,576 human interactions (<xref rid="SD3" ref-type="supplementary-material">Supplementary Fig. 5</xref>). Specifically, residues classified by ECLAIR with a High or
Very High interface potential have a precision of 0.69, and &gt;90% of all 115,576
human interactions with predicted interfaces in Interactome INSIDER have 1 or more residues
that fall into these categories. We supplemented known structural interfaces from
co-crystalized proteins and homology models with our predictions to create structural
interactomes at both the atomic and residue levels (<xref rid="F2" ref-type="fig">Fig.
2a</xref>) in 7 model organisms and human (including all 122,647 human
experimentally-determined binary interactions reported in major databases; see Online
Methods). We used this resource to explore human disease with Interactome INSIDER.</p>
    <sec id="S3">
      <title>Comprehensive evaluation of predicted interfaces</title>
      <p id="P9">We established that our predictions are of high quality through both machine
learning and biological evaluation. We first evaluated the trade-offs between false
positive rate and true positive rate, and between precision and recall for each of the 8
independent sub-classifiers that compose ECLAIR. As expected, we find that as more
informative features are added to subsequent classifiers, the areas under the ROC and
precision-recall curves increase, justifying the use of classifiers trained on more
features for residues where this information is available (<xref rid="SD3" ref-type="supplementary-material">Supplementary Fig. 6</xref>).</p>
      <p id="P10">We next compared ECLAIR to several other prediction methods through two
independent validations. First, we used several readily available predictors<sup><xref rid="R20" ref-type="bibr">20</xref>–<xref rid="R24" ref-type="bibr">24</xref></sup> to predict interfaces for interactions in our testing set. We find that
for the set of interactions for which all classifiers can predict, ECLAIR performs as well
or slightly better than these methods by measures of precision, recall, true positive rate
and false positive rate (<xref rid="F2" ref-type="fig">Fig. 2b</xref>, <xref rid="SD3" ref-type="supplementary-material">Supplementary Fig. 7</xref>). Finally, we applied
ECLAIR to a standard external benchmark set of protein interaction interfaces<sup><xref rid="R25" ref-type="bibr">25</xref></sup> which has been used to evaluate the
performance of 10 other interface prediction methods<sup><xref rid="R26" ref-type="bibr">26</xref></sup>. We find that ECLAIR outperforms all benchmarked methods in accuracy,
and is comparable to the top performers in all other metrics (<xref rid="SD2" ref-type="supplementary-material">Supplementary Table 1</xref>). Furthermore, ECLAIR is
applicable to any interaction, while methods in this benchmark rely on single-protein
structure inputs, making them much less applicable to genome-wide studies. In fact,
86.1% of interactions without structural features contain at least 1 predicted
interface residue at a ECLAIR score corresponding to a precision ≥ 0.6.</p>
      <p id="P11">We also performed &gt;2,000 mutagenesis experiments to measure the rate at which
population variants in our predicted interfaces disrupt interactions compared to variants
within known co-crystal interfaces and non-interfaces (see Material and Methods). Using
our high-throughput yeast two-hybrid assay<sup><xref rid="R27" ref-type="bibr">27</xref></sup>, we find that mutations in our predicted interfaces break their
corresponding interactions at a significantly higher rate than those known to be away from
the interface and at similar rates to mutations in known interfaces. Since it is known
that mutations at protein interfaces are more likely to break interactions<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R27" ref-type="bibr">27</xref></sup>, our
experimental results indicate that there is rich functional signal in our ECLAIR
predictions (<xref rid="F2" ref-type="fig">Fig. 2c</xref>).</p>
    </sec>
    <sec id="S4">
      <title>Functional annotation of disease mutations in structural interactomes</title>
      <p id="P12">Interactome INSIDER is a tool for identifying functionally enriched areas of
protein interactomes, and for browsing our multi-scale structural interactome networks:
198,503 protein interactions whose interfaces have been either experimentally determined,
homology modeled, or predicted using ECLAIR. Interactome INSIDER also includes 56,159
disease mutations from HGMD<sup><xref rid="R28" ref-type="bibr">28</xref></sup> and
ClinVar<sup><xref rid="R29" ref-type="bibr">29</xref></sup>, and 1,300,352 somatic
cancer mutations from COSMIC<sup><xref rid="R30" ref-type="bibr">30</xref></sup> with
their per-disease, pre-calculated enrichment in protein interaction interfaces at the
residue level, domain level, and through atomic clustering. The site includes information
on &gt;600,000 population variants from the Exome Sequencing Project<sup><xref rid="R31" ref-type="bibr">31</xref></sup>, 1000 Genomes Project<sup><xref rid="R32" ref-type="bibr">32</xref></sup> and more<sup><xref rid="R33" ref-type="bibr">33</xref></sup> (see Online Methods). Users can search Interactome INSIDER by protein
to retrieve all interaction partners and their interfaces, or by disease to retrieve all
interaction interfaces that are enriched for mutations of that disease. Additionally,
users can upload their own set of mutations to find how they are distributed in the
interactome and whether they are enriched in any protein interaction interfaces at the
residue, domain, and atomic levels (<xref rid="F3" ref-type="fig">Fig. 3</xref>).</p>
      <p id="P13">We demonstrate the utility of Interactome INSIDER and the validity of its
underlying database by investigating the functional and biological properties of our
predicted interaction interfaces. We measured functional properties of our <italic>in
silico</italic> predicted interfaces (those without prior experimental evidence) and
compared these measurements to those of known interfaces from co-crystal structures. We
find that disease mutations preferentially occur in our predicted interfaces at similar
rates to known interface residues in PDB co-crystal structures (<xref rid="F4" ref-type="fig">Fig. 4a</xref>), indicating the viability of using predicted interfaces
to study molecular disease mechanisms. Furthermore, each higher-confidence bin of
predicted interface residues is more likely to contain disease mutations than the
previous, showing that ECLAIR prediction scores are correlated with true protein function.
We looked at the locations of somatic cancer mutations from COSMIC in our
interface-resolved human interactome. We specifically focused on recurrent cancer
mutations as these are known to be more likely to be functional drivers<sup><xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup>.
We find a marked enrichment of recurrent cancer mutations in our predicted interfaces
compared to outside these interfaces (<xref rid="F4" ref-type="fig">Fig. 4b</xref>). The
same trend is observed inside and outside of known interfaces from co-crystal structures,
suggesting that the functional links between cancer and the potential disruption of
protein interactions can be observed within the entire Interactome INSIDER human interface
dataset. We also looked at the distribution of population variants, and show that their
placement in and out of predicted interfaces matches that of known interfaces, with rarer
mutations showing an enrichment in protein interfaces (<xref rid="F4" ref-type="fig">Fig.
4c</xref>). Furthermore, population variants in our predicted interfaces are more likely
to be damaging to protein function than variants outside of predicted interfaces, as
predicted by PolyPhen-2<sup><xref rid="R36" ref-type="bibr">36</xref></sup> (<xref rid="F4" ref-type="fig">Fig. 4d</xref>) and EVmutation<sup><xref rid="R37" ref-type="bibr">37</xref></sup> (<xref rid="F4" ref-type="fig">Fig. 4e</xref>),
matching the established trend for experimentally determined interfaces<sup><xref rid="R38" ref-type="bibr">38</xref></sup>. We validated many of these biological
trends for interactions lacking structural features (<xref rid="SD3" ref-type="supplementary-material">Supplementary Figs. 8–10</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Note 6</xref>), suggesting the
utility of Interactome INSIDER even in feature-poor interactions and across different
resolution scales.</p>
      <p id="P14">We used Interactome INSIDER to search for sub-networks in the human interactome
that are enriched for mutations associated with a single disease, by calculating the
enrichment of disease mutations in interaction interfaces interactome-wide. This
identified the TGF-β/BMP signaling pathway, which is known to be involved in
juvenile polyposis syndrome (JPS)<sup><xref rid="R39" ref-type="bibr">39</xref></sup>, and
contains multiple proteins harboring JPS mutations (<xref rid="F5" ref-type="fig">Fig.
5a</xref>). We focused on a specific group of mutations in the SMAD4-SMAD8 interface,
which can be found using 3D atomic clustering. Using our mutagenesis Y2H assay, we were
able to test a JPS mutation (SMAD4 Y353S)<sup><xref rid="R40" ref-type="bibr">40</xref></sup>, which is at the interface of SMAD4-SMAD8, and show that it breaks this
interaction, implicating SMAD8 in JPS (<xref rid="F5" ref-type="fig">Fig. 5a</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Fig 11</xref>). Although SMAD8
(also known as SMAD9) has not been reported to harbor JPS mutations in HGMD<sup><xref rid="R28" ref-type="bibr">28</xref></sup>, its involvement in the disease has been
suggested<sup><xref rid="R41" ref-type="bibr">41</xref></sup>, showing the ability of
Interactome INSIDER to implicate new proteins in disease. Y353S is not predicted by ECLAIR
to be at the interface of SMAD4 and another of its binding partners, RASSF5. Indeed,
through our Y2H experiment, Y353S does not break this interaction, demonstrating the
functional insight Interactome INSIDER can provide about differential interfaces and how
they might be relevant to understanding the molecular mechanisms of disease.</p>
    </sec>
    <sec id="S5">
      <title>Disease etiology revealed by partner-specific interfaces</title>
      <p id="P15">Interactome INSIDER enables interrogation of different interfaces for the same
protein, dependent upon its binding partner (<xref rid="F5" ref-type="fig">Fig.
5b</xref>). For the study of protein function and disease, this is especially important as
a protein may maintain different functional pathways through different interfaces, and
disruption of one interface may leave others intact<sup><xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup>. To test this on a
large-scale, we looked at pairs of disease mutations in the human interactome that appear
at interaction interfaces, as predicted by ECLAIR. Similar to previous reports<sup><xref rid="R8" ref-type="bibr">8</xref></sup>, we observed that mutation pairs in the
interface of two interacting proteins are much more likely to cause the same disease than
mutation pairs in other interfaces of the same proteins that do not mediate the given
interaction (<xref rid="F5" ref-type="fig">Fig. 5c</xref>). We also find that mutation
pairs on the same protein, but in separate interfaces with different binding partners tend
to cause different diseases (<xref rid="F5" ref-type="fig">Fig. 5d</xref>). This trend is
observed in both known and predicted interfaces. These results indicate that Interactome
INSIDER can be used to form functional hypotheses about the specificity of mutations to
specific interactions and molecular pathways.</p>
      <p id="P16">We next used Interactome INSIDER to find sub-networks in the human interactome
enriched for mutations associated with a single disease. We uncovered a set of interacting
proteins known to harbor mutations causal for hypertrophic cardiomyopathy (HCM)<sup><xref rid="R42" ref-type="bibr">42</xref></sup> and thereby recapitulated the core
constituents of a known KEGG pathway related to the same disease (<xref rid="F6" ref-type="fig">Fig. 6</xref>). These proteins were identified by enrichment of disease
mutations in their shared interaction interfaces and, in the case of TNNI3-TNNC1, using
cross-interface atomic clustering of disease mutation positions in 3D (features available
via the Interactome INSDIER website). In addition to identifying known members of the HCM
pathway, Interactome INSIDER also identified several additional proteins, including CSRP3,
MYOM1, ANKRD and TCAP, which are not part of the known KEGG pathway, but carry HCM
mutations enriched at their respective interaction interfaces with members of the pathway.
We also identify a protein, TNNT1, which, although it contains no HCM mutations of its
own, can be implicated in HCM through its interactions with two proteins TPM1 and TNNC1,
which are enriched for HCM mutations at their interfaces with TNNT1. Finally, we note that
Interactome INSIDER reveals cases of partner-specific interfaces in this pathway. For
instance, the known HCM pathway protein TTN’s interface with ACTA1 is enriched for
HCM mutations, and ACTA1 mutations are increasingly linked to HCM<sup><xref rid="R43" ref-type="bibr">43</xref></sup>. On the other hand, a separate interface of ACTA1 with
its binding partner dystrophin is enriched with mutations causing a distinct disorder,
actin myopathy<sup><xref rid="R44" ref-type="bibr">44</xref></sup>. This shows how ACTA1
can play roles in two different diseases through separate interaction interfaces with TTN
and dystrophin, and demonstrates Interactome INSIDER’s unique ability to discover
such cases of differential function mirroring differential interfaces.</p>
    </sec>
  </sec>
  <sec sec-type="discussion" id="S6">
    <title>DISCUSSION</title>
    <p id="P17">We anticipate Interactome INSIDER will help to bridge the divide between
genomic-scale datasets and structural proteomic analyses. Now that large-scale sequencing
data from many contexts are readily available, for instance from whole-genome/whole-exome
population variant studies<sup><xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R45" ref-type="bibr">45</xref></sup> and cancer studies<sup><xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R47" ref-type="bibr">47</xref></sup>, researchers have become
increasingly interested in ways to assess the potential functional consequences of variants
on a genomic scale<sup><xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R49" ref-type="bibr">49</xref></sup>. Recently we and others have developed methods to
predict functional cancer driver mutations by finding hotspots of mutations in the
structural proteome<sup><xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R50" ref-type="bibr">50</xref></sup>. With the comprehensive map of protein interfaces
presented, we can now go a step further to predict specific etiologies of cancer and disease
based on induced biophysical effects<sup><xref rid="R51" ref-type="bibr">51</xref>,<xref rid="R52" ref-type="bibr">52</xref></sup> that may break interactions. Because our
interface map is partner-specific, it can also be applied to predict pleiotropic effects,
wherein several mutations in a single protein may affect different pathways depending upon
which binding interfaces are mutated<sup><xref rid="R8" ref-type="bibr">8</xref></sup>. This
could be the basis for designing new therapeutics and for rational drug design to
selectively target specific protein functional sites<sup><xref rid="R53" ref-type="bibr">53</xref></sup>.</p>
    <p id="P18">We have shown that hyperparameter optimization, which is surprisingly lacking in
much of the current literature, can drastically improve the performance of classifiers for
biological classification studies. The tiered ensemble form of the ECLAIR classifier
represents a broadly applicable paradigm in practical machine learning that could be readily
applied to solving other problems with large amounts of non-uniformly missing data, which
very frequently occur in biology due to study biases.</p>
    <p id="P19">With future increases to the scale of biological databases from which we derive
features, we expect that Interactome INSIDER will come to encompass even higher confidence
predictions for many more interactions, thereby becoming increasingly applicable to
functional studies. This may also address some limitations of structural databases today.
For instance, the PDB is depleted of disordered proteins<sup><xref rid="R54" ref-type="bibr">54</xref></sup>, and it has been shown that disordered regions can form
interfaces<sup><xref rid="R55" ref-type="bibr">55</xref></sup>. Since ECLAIR has not
been trained on disordered interfaces, it is unlikely to predict new disordered interfaces.
However, the ensemble classifier structure of ECLAIR uniquely positions it to incorporate
all newly-available evidence into interface predictions without sacrificing quality or
scale, ensuring a high quality map of interaction interfaces now and in the future.
Furthermore, the addition of new variants, especially cancer mutations and population
variants from large-scale sequencing studies, will only increase the value of performing
systems-level explorations with Interactome INSIDER.</p>
  </sec>
  <sec id="S7" specific-use="web-only">
    <title>ONLINE METHODS</title>
    <sec id="S8">
      <title>Interaction datasets</title>
      <p id="P20">We compiled binary protein interactions available for <italic>H.
sapiens</italic>, <italic>D. melanogaster</italic>, <italic>S. cerevisiae</italic>,
<italic>C. elegans</italic>, <italic>A. thaliana</italic>, <italic>E. coli</italic>,
<italic>S. pombe</italic>, and <italic>M. musculus</italic> from 7 primary interaction
databases. These databases include IMEx<sup><xref rid="R56" ref-type="bibr">56</xref></sup> partners DIP<sup><xref rid="R57" ref-type="bibr">57</xref></sup>,
IntAct<sup><xref rid="R58" ref-type="bibr">58</xref></sup>, and MINT<sup><xref rid="R59" ref-type="bibr">59</xref></sup>, IMEx observer BioGRID<sup><xref rid="R60" ref-type="bibr">60</xref></sup>, and additional sources iRefWeb<sup><xref rid="R61" ref-type="bibr">61</xref></sup>, HPRD<sup><xref rid="R62" ref-type="bibr">62</xref></sup>, and MIPS<sup><xref rid="R63" ref-type="bibr">63</xref></sup>.
Furthermore, iRefWeb combines interaction data from BIND<sup><xref rid="R64" ref-type="bibr">64</xref></sup>, CORUM<sup><xref rid="R65" ref-type="bibr">65</xref></sup>, MPact<sup><xref rid="R66" ref-type="bibr">66</xref></sup>,
OPHID<sup><xref rid="R67" ref-type="bibr">67</xref></sup>, and MPPI<sup><xref rid="R68" ref-type="bibr">68</xref></sup>. We filtered these interactions using the
PSI-MI<sup><xref rid="R69" ref-type="bibr">69</xref></sup> evidence codes of assays
that can determine experimental binary interactions (<xref rid="SD2" ref-type="supplementary-material">Supplementary Table 2</xref>), as these are
interactions where proteins are known to share a direct binding interface that we can then
predict<sup><xref rid="R5" ref-type="bibr">5</xref></sup>. In total, we curated
198,503 interactions in these 8 species including the full experimentally determined
binary interactome in human (122,647 interactions) (<xref rid="SD1" ref-type="supplementary-material">Supplementary Note 1</xref>). Those interactions with
known interface residues based on available co-crystal structures in the Protein Data Bank
(PDB)<sup><xref rid="R70" ref-type="bibr">70</xref></sup> were set aside for use in
training and testing the classifier. Interactions without known interface residues
comprise the set for which we make predictions.</p>
    </sec>
    <sec id="S9">
      <title>Testing and training sets for interface residue prediction</title>
      <p id="P21">For those interactions with known co-crystal structures in the PDB, we calculate
interface residues for their specific binding partners. To identify UniProt protein
sequences in the PDB, we use SIFTS<sup><xref rid="R71" ref-type="bibr">71</xref></sup>,
which provides a mapping of PDB-indexed residues to UniProt-indexed residues<sup><xref rid="R33" ref-type="bibr">33</xref></sup>. For each interaction and representative
co-crystal structure, interface residues are calculated by assessing the change in solvent
accessible surface area of the proteins in complex and apart using NACCESS<sup><xref rid="R72" ref-type="bibr">72</xref></sup>. Any residue that is at the surface of a
protein (≥15% exposed surface) and whose solvent accessible surface area
(SASA) decreases by ≥1.0 Å<sup>2</sup> in complex is considered to be at
the interface. We aggregate interface residues across all available structures in the PDB
for a given interaction, wherein a residue is considered to be at the interface of the
interaction if it has been calculated to be at the interface in one or more co-crystal
structures of that interaction (all other residues are considered to be away from the
interface). In building our final training and testing sets, we only consider interactions
for which aggregated co-crystal structures have combined to cover at least 50% of
UniProt residues for both interacting proteins.</p>
      <p id="P22">The training and testing sets each include a random selection of 400
interactions with known co-crystal structures, of which 200 are heterodimers and 200 are
homodimers (<xref rid="SD2" ref-type="supplementary-material">Supplementary Table
3</xref>). To ensure an unbiased performance evaluation, we disallowed any homologous
interactions (i.e. interactions whose structures could be used as templates for homology
modeling) between the training and testing set. We also disallowed repeated proteins
between the two sets to avoid simply reporting a remembered shared interface between a
protein and multiple binding partners, thereby artificially elevating the performance of
our classifier on the testing set.</p>
    </sec>
    <sec id="S10">
      <title>Hyperparameter optimization with TPE</title>
      <p id="P23">To train our ensemble of classifiers that comprise ECLAIR, we used the
tree-structured Parzen estimator approach (TPE)<sup><xref rid="R19" ref-type="bibr">19</xref></sup>, a Bayesian method for optimizing hyperparameters for machine
learning algorithms. TPE models the probability distribution <italic>p(x|y)</italic> of
hyperparameters given evaluated loss from a defined objective function,
<italic>L(x)</italic>. We selected the following loss function to minimize based on
classical hyperparameter inputs and residue window sizes: <disp-formula id="FD1"><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:mi>L</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>θ</mml:mi><mml:mo>,</mml:mo><mml:mi>w</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:munder><mml:mo>min</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>∈</mml:mo><mml:mo stretchy="false">{</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:munder><mml:mo>{</mml:mo><mml:msub><mml:mi mathvariant="italic">AUROC</mml:mi><mml:mrow><mml:mi>θ</mml:mi><mml:mo>,</mml:mo><mml:mi>w</mml:mi><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>}</mml:mo></mml:mrow></mml:math></disp-formula> where <italic>x</italic> is comprised of
<italic>θ</italic>, a set of hyperparameters, and <italic>w</italic>, a set of
residue window sizes. The evaluation metric, <italic>AUROC<sub>n</sub>,</italic> is the
area under the roc curve for the n<sup>th</sup> left-out evaluation fold in a three-fold
cross-validation scheme. We then used TPE to randomly sample an initial uniform
distribution of each of our hyperparameters and window sizes and evaluate the loss
function for each random set of inputs. TPE then replaces this initial distribution with a
new distribution built on the results from regions of the sampled distribution that
minimize <italic>L(x)</italic>: <disp-formula id="FD2"><mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo>∣</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>l</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.16667em"/><mml:mi>y</mml:mi><mml:mo>&lt;</mml:mo><mml:msup><mml:mi>y</mml:mi><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mi>g</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.16667em"/><mml:mi>y</mml:mi><mml:mo>≤</mml:mo><mml:msup><mml:mi>y</mml:mi><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math></disp-formula> where <italic>y<sup>*</sup></italic> is a quantile
γ of the observed y values so that <italic>p(y &lt;
y<sup>*</sup>)</italic> = γ. Importantly,
<italic>y<sup>*</sup></italic> is guaranteed to be greater than the minimum
observed loss, so that some points are used to build <italic>l(x)</italic>. TPE then
chooses candidate hyperparameters to sample as those representing the greatest expected
improvement, <italic>EI</italic>, according to the expression: <disp-formula id="FD3"><mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:msub><mml:mrow><mml:mi>E</mml:mi><mml:mi>I</mml:mi></mml:mrow><mml:msup><mml:mi>y</mml:mi><mml:mo>∗</mml:mo></mml:msup></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>γ</mml:mi><mml:msup><mml:mi>y</mml:mi><mml:mo>∗</mml:mo></mml:msup><mml:mi>l</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>-</mml:mo><mml:mi>l</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mo>-</mml:mo><mml:mo>∞</mml:mo></mml:mrow><mml:msup><mml:mi>y</mml:mi><mml:mo>∗</mml:mo></mml:msup></mml:msubsup><mml:mrow><mml:mi>y</mml:mi><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>y</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>d</mml:mi><mml:mi>y</mml:mi></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mi>γ</mml:mi><mml:mi>l</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>g</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mo>∝</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>γ</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>g</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></disp-formula></p>
      <p id="P24">To maximize <italic>EI</italic>, the algorithm picks points <italic>x</italic>
with high probability under <italic>l(x)</italic> and low probability under
<italic>g(x)</italic>. Each iteration of the algorithm returns
<italic>x<sup>*</sup></italic>, the next set of hyperparameters to sample,
with the greatest <italic>EI</italic> based on previously sampled points.</p>
    </sec>
    <sec id="S11">
      <title>Training the classifier</title>
      <p id="P25">The ECLAIR classifier was trained in three stages, using a custom wrapper of the
scikit-learn<sup><xref rid="R73" ref-type="bibr">73</xref></sup> random
forest<sup><xref rid="R74" ref-type="bibr">74</xref></sup> classifier to allow for use
of TPE to search both algorithm hyperparameters and residue window sizes simultaneously.
In all cross-validations performed, we allowed TPE to search the following
hyperparameters, beginning with uniform distributions of the indicated ranges: (1) minimum
samples per leaf (0–1000), (2) maximum fraction of features per tree
(0–1), and (3) split criterion (entropy or gini diversity index). The number of
estimators (decision trees) in each random forest was fixed at either 200 for training the
feature selection classifiers, or 500 for training the full ensemble. We also allowed TPE
to search over residue window sizes (± 0–5 residues for a total window of
up to 11 residues, centered on the residue of interest). This was achieved by allowing
extra features for neighboring residues to be included at the time of algorithm
initialization.</p>
      <p id="P26">In the first stage of training, cross-validation using TPE was performed on
classifiers trained using only features from 1 of the 5 feature categories. The feature or
set of features from each category with the minimum loss was selected to represent that
category in building the ensemble classifier (<xref rid="SD2" ref-type="supplementary-material">Supplementary Table 4</xref>). In the second stage,
the ensemble classifier was built of 8 random forest classifiers, each trained on
different subsets of feature categories, and hyperparameters and window sizes were again
chosen using cross-validation and TPE (<xref rid="SD2" ref-type="supplementary-material">Supplementary Table 5</xref>). In the final stage, following performance measurement on
the testing set, the 8 sub-classifiers were retrained using the full set of 3,447
interactions with at least 50% UniProt residue coverage in the PDB, using the same
hyperparameters and window sizes found in the previous step.</p>
    </sec>
    <sec id="S12">
      <title>Evaluating the ensemble</title>
      <p id="P27">After training and optimizing using only the training set, we predicted
interface residues in a completely orthogonal testing set. For each sub-classifier of the
ensemble, all residues in the testing set that could be predicted (given the full set of
necessary features or a superset) were ranked according to their raw prediction scores to
produce ROC and precision-recall plots.</p>
    </sec>
    <sec id="S13">
      <title>Benchmarking against other methods</title>
      <p id="P28">Interfaces for interactions in our testing set were computed using several
popular interface prediction methods<sup><xref rid="R20" ref-type="bibr">20</xref>–<xref rid="R24" ref-type="bibr">24</xref></sup>. We compiled a set
of representative protein structures from the PDB for each protein in our testing set,
selecting the structure with the highest UniProt residue content based on SIFTS and
excluding any PDB structures of interacting protein pairs from our testing set. We then
evaluated the precision, recall, and false positive rate for proteins that were able to be
classified by all methods. These represent point estimates of these metrics for the
external methods with binary prediction scores.</p>
      <p id="P29">We also compared ECLAIR to 10 popular methods for interface prediction by
predicting interfaces in a standard benchmark set of protein complexes<sup><xref rid="R25" ref-type="bibr">25</xref></sup> (<xref rid="SD2" ref-type="supplementary-material">Supplementary Table 1</xref>). Here, we followed the experimental procedures laid out
by Maheshwari <italic>et al.</italic><sup><xref rid="R26" ref-type="bibr">26</xref></sup>,
and excluded complexes in which the receptor is &lt;50 or &gt;600 amino acids, where the
interface is made up of &lt;20 residues, or where multiple interfaces are present.</p>
    </sec>
    <sec id="S14">
      <title>Predicting new interfaces</title>
      <p id="P30">We retrained the ensemble using all available co-crystal structures, including
those from both testing and training sets, a standard machine learning practice that makes
maximal use of labeled data<sup><xref rid="R75" ref-type="bibr">75</xref></sup>. Using
this fully trained ensemble of classifiers, we predicted interface residues for the
remaining 185,957 interactions not resolved by either PDB structures or homology models.
Sub-classifiers were ordered based on the number and information content of features used
in their training. Each residue was then predicted by only the top ranking classifier of
the ensemble trained on the full set or a subset of available features for that
residue.</p>
    </sec>
    <sec id="S15">
      <title>Interface enrichment and 3D atomic clustering</title>
      <p id="P31">Interface domain enrichment, residue enrichment, and 3D atomic clustering can be
calculated through the Interactome INSIDER web interface. For enrichments presented in
this study, we accessed all disease mutations from the Human Gene Mutation Database
(HGMD)<sup><xref rid="R28" ref-type="bibr">28</xref></sup> and ClinVar<sup><xref rid="R29" ref-type="bibr">29</xref></sup>, recurrent cancer mutations appearing ge; 6
times in COSMIC<sup><xref rid="R30" ref-type="bibr">30</xref></sup>, and population
variants from the Exome Sequencing Project<sup><xref rid="R31" ref-type="bibr">31</xref></sup> to compute the log odds ratio: <disp-formula id="FD4"><mml:math id="M4" display="block" overflow="scroll"><mml:mrow><mml:mi mathvariant="italic">LOR</mml:mi><mml:mo>=</mml:mo><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.16667em"/><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mstyle scriptlevel="1"><mml:mfrac><mml:msub><mml:mi>p</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mstyle><mml:mstyle scriptlevel="1"><mml:mfrac><mml:msub><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mstyle></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula> where <italic>p<sub>1</sub></italic> is the probability of a
mutation or variant being at the interface and <italic>p<sub>2</sub></italic> is the
probability of any residue being at the interface. We computed the log odds ratio for
residues in each of the interface prediction potential categories. We also computed the
log odds ratio for interactions with known interfaces from PDB co-crystal structures,
defined as all known interface residues from NACCESS calculations and all residues in
Pfam<sup><xref rid="R76" ref-type="bibr">76</xref></sup> domains with ≥ 5
interface residues. For the disease mutation enrichment analysis (<xref rid="F4" ref-type="fig">Fig. 4a</xref>, we used all disease mutations available from HGMD, and
the following numbers of mutations occurred in each category: 10,196 Very Low, 10,547 Low,
2,970 Medium, 1,135 High, and 305 Very High. We also computed enrichment of 18,638
mutations in known interfaces and 17,760 mutations in known non-interfaces (from
co-crystal structure evidence).</p>
      <p id="P32">To perform 3D atomic clustering of amino acid loci of interest, we used an
established method<sup><xref rid="R35" ref-type="bibr">35</xref></sup> for clustering and
empirical <italic>p</italic>-value calculation and applied it to multi-protein clustering,
wherein clusters can occur across an interaction interface. Here, we perform
complete-linkage clustering<sup><xref rid="R77" ref-type="bibr">77</xref></sup> in the
shared 3D space of both proteins, and iteratively, and randomly rearrange mutations in
each protein to produce an empirical null distribution of cluster sizes.</p>
    </sec>
    <sec id="S16">
      <title>Mutagenesis validation experiments</title>
      <p id="P33">We performed mutagenesis experiments in which we introduced random human
population variants from the Exome Sequencing Project<sup><xref rid="R31" ref-type="bibr">31</xref></sup> into known and predicted interfaces. We randomly selected mutations
of predicted interface residues in each of the top four ECLAIR categories (Low –
Very High). As positive and negative controls, we also selected random mutations of known
interface and non-interface residues in co-crystal structures in the PDB. The selected
mutations were then introduced into the proteins according to our previously published
Clone-seq pipeline<sup><xref rid="R27" ref-type="bibr">27</xref></sup> and their impact
(either disrupting or maintaining the interaction) was assessed using our yeast two-hybrid
assay (<xref rid="SD1" ref-type="supplementary-material">Supplementary Note 7</xref>). In
this manner, we tested the impact of 2,164 mutations: 1,664 in our predicted interfaces
and 500 in known interface and non-interface residues from co-crystal structures. In <xref rid="F2" ref-type="fig">Figure 2c</xref>, we report the fraction of tested interface
residue mutations that caused a disruption of the given interaction for each of the
interface residue bins.</p>
    </sec>
    <sec id="S17">
      <title>Web server</title>
      <p id="P34">Interactome INSIDER is deployed as an interactive web server (<ext-link ext-link-type="uri" xlink:href="http://interactomeinsider.yulab.org">http://interactomeinsider.yulab.org</ext-link>) containing known and predicted
interfaces for 198,503 protein interactions in 8 species, as well as variants and
functional annotations mapped relative to the residues in the human proteome. For each
interaction, the most reliable, high-resolution model is presented, i.e. co-crystal
structures are always displayed in lieu of homology models, and all remaining unresolved
interactions are predicted by our ECLAIR classifier. Co-crystal structures are derived
from the PDB, with extraneous chains removed for each interaction, and homology models are
computed by MODELLER<sup><xref rid="R11" ref-type="bibr">11</xref></sup> and downloaded
from Interactome3D<sup><xref rid="R12" ref-type="bibr">12</xref></sup>. For both types of
structural model, we computed all residues at the interface over all available models, and
allow users to view any model from which a unique interface residue has been calculated.
For predicted interfaces, a non-redundant set of single protein models are shown when
available, with locations of predicted interface residues indicated. In total, the
resource contains 7,135 interactions with co-crystal structures, 5,411 with homology
models, and 185,957 with predicted interfaces.</p>
      <p id="P35">Interactome INSIDER also includes pre-calculated enrichment of mutations derived
from several sources: 56,159 disease mutations from HGMD<sup><xref rid="R28" ref-type="bibr">28</xref></sup> and ClinVar<sup><xref rid="R29" ref-type="bibr">29</xref></sup> and 1,300,352 somatic cancer mutations from COSMIC<sup><xref rid="R30" ref-type="bibr">30</xref></sup>. It also includes 194,396 population
variants from the 1000 Genomes Project<sup><xref rid="R32" ref-type="bibr">32</xref></sup>, 425,115 from the Exome Sequencing Project<sup><xref rid="R31" ref-type="bibr">31</xref></sup>, and 54,165 catalogued by UniProt<sup><xref rid="R33" ref-type="bibr">33</xref></sup>. Predictions of deleteriousness for all variants and
any user-submitted variants within the curated interactomes are obtained from
PolyPhen-2<sup><xref rid="R36" ref-type="bibr">36</xref></sup> and SIFT<sup><xref rid="R78" ref-type="bibr">78</xref></sup>, and biophysical property change guides
(i.e. polar to non-polar, hydrophobic to hydrophilic) are also displayed for convenience.
Mutation and variant enrichment analyses can be triggered by the user for existing
variants or for user-submitted sets within interacting protein domains, residues, and 3D
clustering using the atomic coordinates of structures when available.</p>
      <p id="P36">Downloads of known and predicted interface residues on a per-interaction basis
are available as plain text and as .bed files that can be visualized alongside other
genomic landmarks in the UCSC genome browser<sup><xref rid="R79" ref-type="bibr">79</xref></sup>. Per-protein visualization tracks, with interface residues of all
interaction partners are also available on the “Downloads” page, along
with bulk downloads of interfaces for entire species.</p>
    </sec>
    <sec id="S18" sec-type="results">
      <title>Statistics</title>
      <p id="P37">Statistical analyses were performed using a two-sided <italic>Z</italic> test or
a two-sided Mann-Whitney <italic>U</italic> test, as indicated in the figure captions.
Exact <italic>P</italic> values are provided for all compared groups, and comparisons with
a two-side <italic>P</italic> value &gt; 0.05 are considered not significant, with all
others considered not significant (n.s.).</p>
    </sec>
    <sec id="S19">
      <title>Code and data availability</title>
      <p id="P38">Custom code used in this study is freely available at <ext-link ext-link-type="uri" xlink:href="https://github.com/hyulab/ECLAIR">https://github.com/hyulab/ECLAIR</ext-link> and as Supplementary Software. Data
produced by this study is available for browsing and bulk download at <ext-link ext-link-type="uri" xlink:href="http://interactomeinsider.yulab.org">http://interactomeinsider.yulab.org</ext-link>. Additional information is available in
the Life Sciences Reporting Summary.</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material" id="S20">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="SD1">
      <label>1</label>
      <media xlink:href="NIHMS925038-supplement-1.docx" orientation="portrait" xlink:type="simple" id="d36e1444" position="anchor"/>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="SD2">
      <label>2</label>
      <media xlink:href="NIHMS925038-supplement-2.doc" orientation="portrait" xlink:type="simple" id="d36e1448" position="anchor"/>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="SD3">
      <label>3</label>
      <media xlink:href="NIHMS925038-supplement-3.pdf" orientation="portrait" xlink:type="simple" id="d36e1452" position="anchor"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="S21">
    <p>The authors would like to thank G. Hooker, D. Bindel, and K. Weinberger for helpful
discussions. This work was supported by National Institute of General Medical Sciences
grants (R01 GM097358, R01 GM104424, R01 GM124559); National Cancer Institute grant (R01
CA167824); Eunice Kennedy Shriver National Institute of Child Health and Human Development
grant (R01 HD082568); National Human Genome Research Institute grant (UM1 HG009393);
National Science Foundation grant (DBI-1661380); Simons Foundation Autism Research
Initiative grant (367561) to H.Y.</p>
  </ack>
  <fn-group>
    <fn id="FN3" fn-type="con">
      <p>
        <bold>Author Contributions</bold>
      </p>
      <p>M.J.M, J.F.B, S.L., and H.Y. conceived the study. H.Y. oversaw all aspects of the study.
M.J.M., J.F.B., S.L., and A.R performed computational analyses. M.J.M., and J.F.B.
designed ECLAIR. J.F.B. designed the web interface. R.F., J.L., and X.W. performed
laboratory experiments. M.J.M wrote the manuscript with input from J.F.B., S.L., and H.Y.
All authors edited and approved of the final manuscript.</p>
    </fn>
    <fn fn-type="COI-statement" id="FN4">
      <p>
        <bold>Competing Financial Interests</bold>
      </p>
      <p>The authors declare no competing financial interests.</p>
    </fn>
  </fn-group>
  <ref-list>
    <ref id="R1">
      <label>1</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rolland</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A proteome-scale map of the human interactome network</article-title>
        <source>Cell</source>
        <volume>159</volume>
        <fpage>1212</fpage>
        <lpage>1226</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">25416956</pub-id>
      </element-citation>
    </ref>
    <ref id="R2">
      <label>2</label>
      <element-citation publication-type="journal">
        <collab>Arabidopsis Interactome Mapping C</collab>
        <article-title>Evidence for network evolution in an Arabidopsis interactome
map</article-title>
        <source>Science</source>
        <volume>333</volume>
        <fpage>601</fpage>
        <lpage>607</lpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21798944</pub-id>
      </element-citation>
    </ref>
    <ref id="R3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>High-quality binary protein interaction map of the yeast interactome
network</article-title>
        <source>Science</source>
        <volume>322</volume>
        <fpage>104</fpage>
        <lpage>110</lpage>
        <year>2008</year>
        <pub-id pub-id-type="pmid">18719252</pub-id>
      </element-citation>
    </ref>
    <ref id="R4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vo</surname>
            <given-names>TV</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A Proteome-wide Fission Yeast Interactome Reveals Network Evolution
Principles from Yeasts to Human</article-title>
        <source>Cell</source>
        <volume>164</volume>
        <fpage>310</fpage>
        <lpage>323</lpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">26771498</pub-id>
      </element-citation>
    </ref>
    <ref id="R5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Das</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>HINT: High-quality protein interactomes and their applications in
understanding human disease</article-title>
        <source>BMC Syst Biol</source>
        <volume>6</volume>
        <fpage>92</fpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22846459</pub-id>
      </element-citation>
    </ref>
    <ref id="R6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sahni</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Widespread macromolecular interaction perturbations in human genetic
disorders</article-title>
        <source>Cell</source>
        <volume>161</volume>
        <fpage>647</fpage>
        <lpage>660</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">25910212</pub-id>
      </element-citation>
    </ref>
    <ref id="R7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gerstein</surname>
            <given-names>MB</given-names>
          </name>
        </person-group>
        <article-title>Relating three-dimensional structures to protein networks provides
evolutionary insights</article-title>
        <source>Science</source>
        <volume>314</volume>
        <fpage>1938</fpage>
        <lpage>1941</lpage>
        <year>2006</year>
        <pub-id pub-id-type="pmid">17185604</pub-id>
      </element-citation>
    </ref>
    <ref id="R8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Three-dimensional reconstruction of protein networks provides insight into
human genetic disease</article-title>
        <source>Nat Biotechnol</source>
        <volume>30</volume>
        <fpage>159</fpage>
        <lpage>164</lpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22252508</pub-id>
      </element-citation>
    </ref>
    <ref id="R9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuhlbrandt</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Cryo-EM enters a new era</article-title>
        <source>eLife</source>
        <volume>3</volume>
        <fpage>e03678</fpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">25122623</pub-id>
      </element-citation>
    </ref>
    <ref id="R10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Halperin</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wolfson</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nussinov</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Principles of docking: An overview of search algorithms and a guide to
scoring functions</article-title>
        <source>Proteins</source>
        <volume>47</volume>
        <fpage>409</fpage>
        <lpage>443</lpage>
        <year>2002</year>
        <pub-id pub-id-type="pmid">12001221</pub-id>
      </element-citation>
    </ref>
    <ref id="R11">
      <label>11</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sali</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Blundell</surname>
            <given-names>TL</given-names>
          </name>
        </person-group>
        <article-title>Comparative protein modelling by satisfaction of spatial
restraints</article-title>
        <source>J Mol Biol</source>
        <volume>234</volume>
        <fpage>779</fpage>
        <lpage>815</lpage>
        <year>1993</year>
        <pub-id pub-id-type="pmid">8254673</pub-id>
      </element-citation>
    </ref>
    <ref id="R12">
      <label>12</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mosca</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Céol</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aloy</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Interactome3D: adding structural details to protein
networks</article-title>
        <source>Nature methods</source>
        <volume>10</volume>
        <fpage>47</fpage>
        <lpage>53</lpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">23399932</pub-id>
      </element-citation>
    </ref>
    <ref id="R13">
      <label>13</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hopf</surname>
            <given-names>TA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sequence co-evolution gives 3D contacts and structures of protein
complexes</article-title>
        <source>eLife</source>
        <volume>3</volume>
        <year>2014</year>
      </element-citation>
    </ref>
    <ref id="R14">
      <label>14</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hwang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Vreven</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Weng</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Binding interface prediction by combining protein-protein docking
results</article-title>
        <source>Proteins</source>
        <volume>82</volume>
        <fpage>57</fpage>
        <lpage>66</lpage>
        <year>2014</year>
      </element-citation>
    </ref>
    <ref id="R15">
      <label>15</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>QC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Structure-based prediction of protein-protein interactions on a genome-wide
scale</article-title>
        <source>Nature</source>
        <volume>490</volume>
        <fpage>556</fpage>
        <lpage>560</lpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">23023127</pub-id>
      </element-citation>
    </ref>
    <ref id="R16">
      <label>16</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garzon</surname>
            <given-names>JI</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A computational interactome and functional annotation for the human
proteome</article-title>
        <source>eLife</source>
        <volume>5</volume>
        <year>2016</year>
      </element-citation>
    </ref>
    <ref id="R17">
      <label>17</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morcos</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Direct-coupling analysis of residue coevolution captures native contacts
across many protein families</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of
America</source>
        <volume>108</volume>
        <fpage>E1293</fpage>
        <lpage>1301</lpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">22106262</pub-id>
      </element-citation>
    </ref>
    <ref id="R18">
      <label>18</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lockless</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Ranganathan</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Evolutionarily conserved pathways of energetic connectivity in protein
families</article-title>
        <source>Science</source>
        <volume>286</volume>
        <fpage>295</fpage>
        <lpage>299</lpage>
        <year>1999</year>
        <pub-id pub-id-type="pmid">10514373</pub-id>
      </element-citation>
    </ref>
    <ref id="R19">
      <label>19</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bergstra</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Bardenet</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bengio</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kégl</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Algorithms for hyper-parameter optimization</article-title>
        <source>Advances in Neural Information Processing Systems</source>
        <fpage>2546</fpage>
        <lpage>2554</lpage>
        <year>2011</year>
      </element-citation>
    </ref>
    <ref id="R20">
      <label>20</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kufareva</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Budagyan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Raush</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Totrov</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Abagyan</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>PIER: protein interface recognition for structural
proteomics</article-title>
        <source>Proteins</source>
        <volume>67</volume>
        <fpage>400</fpage>
        <lpage>417</lpage>
        <year>2007</year>
        <pub-id pub-id-type="pmid">17299750</pub-id>
      </element-citation>
    </ref>
    <ref id="R21">
      <label>21</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Protein binding site prediction using an empirical scoring
function</article-title>
        <source>Nucleic Acids Res</source>
        <volume>34</volume>
        <fpage>3698</fpage>
        <lpage>3707</lpage>
        <year>2006</year>
        <pub-id pub-id-type="pmid">16893954</pub-id>
      </element-citation>
    </ref>
    <ref id="R22">
      <label>22</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Porollo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Meller</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Prediction-based fingerprints of protein-protein
interactions</article-title>
        <source>Proteins</source>
        <volume>66</volume>
        <fpage>630</fpage>
        <lpage>645</lpage>
        <year>2007</year>
        <pub-id pub-id-type="pmid">17152079</pub-id>
      </element-citation>
    </ref>
    <ref id="R23">
      <label>23</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>de Vries</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Bonvin</surname>
            <given-names>AM</given-names>
          </name>
        </person-group>
        <article-title>CPORT: a consensus interface predictor and its performance in
prediction-driven docking with HADDOCK</article-title>
        <source>PloS one</source>
        <volume>6</volume>
        <fpage>e17695</fpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21464987</pub-id>
      </element-citation>
    </ref>
    <ref id="R24">
      <label>24</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jordan</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>El-Manzalawy</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dobbs</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Honavar</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Predicting protein-protein interface residues using local surface
structural similarity</article-title>
        <source>BMC Bioinformatics</source>
        <volume>13</volume>
        <fpage>41</fpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22424103</pub-id>
      </element-citation>
    </ref>
    <ref id="R25">
      <label>25</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hwang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Vreven</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Janin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Weng</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Protein-protein docking benchmark version 4.0</article-title>
        <source>Proteins</source>
        <volume>78</volume>
        <fpage>3111</fpage>
        <lpage>3114</lpage>
        <year>2010</year>
        <pub-id pub-id-type="pmid">20806234</pub-id>
      </element-citation>
    </ref>
    <ref id="R26">
      <label>26</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maheshwari</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Brylinski</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Predicting protein interface residues using easily accessible on-line
resources</article-title>
        <source>Brief Bioinform</source>
        <volume>16</volume>
        <fpage>1025</fpage>
        <lpage>1034</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">25797794</pub-id>
      </element-citation>
    </ref>
    <ref id="R27">
      <label>27</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A massively parallel pipeline to clone DNA variants and examine molecular
phenotypes of human disease mutations</article-title>
        <source>PLoS Genet</source>
        <volume>10</volume>
        <fpage>e1004819</fpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">25502805</pub-id>
      </element-citation>
    </ref>
    <ref id="R28">
      <label>28</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stenson</surname>
            <given-names>PD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Human Gene Mutation Database: building a comprehensive mutation
repository for clinical and molecular genetics, diagnostic testing and personalized
genomic medicine</article-title>
        <source>Hum Genet</source>
        <volume>133</volume>
        <fpage>1</fpage>
        <lpage>9</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24077912</pub-id>
      </element-citation>
    </ref>
    <ref id="R29">
      <label>29</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Landrum</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ClinVar: public archive of interpretations of clinically relevant
variants</article-title>
        <source>Nucleic Acids Res</source>
        <volume>44</volume>
        <fpage>D862</fpage>
        <lpage>868</lpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">26582918</pub-id>
      </element-citation>
    </ref>
    <ref id="R30">
      <label>30</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Forbes</surname>
            <given-names>SA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>COSMIC: exploring the world’s knowledge of somatic mutations in
human cancer</article-title>
        <source>Nucleic Acids Res</source>
        <volume>43</volume>
        <fpage>D805</fpage>
        <lpage>811</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">25355519</pub-id>
      </element-citation>
    </ref>
    <ref id="R31">
      <label>31</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Analysis of 6,515 exomes reveals the recent origin of most human
protein-coding variants</article-title>
        <source>Nature</source>
        <volume>493</volume>
        <fpage>216</fpage>
        <lpage>220</lpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">23201682</pub-id>
      </element-citation>
    </ref>
    <ref id="R32">
      <label>32</label>
      <element-citation publication-type="journal">
        <collab>Genomes Project C et al</collab>
        <article-title>A global reference for human genetic variation</article-title>
        <source>Nature</source>
        <volume>526</volume>
        <fpage>68</fpage>
        <lpage>74</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">26432245</pub-id>
      </element-citation>
    </ref>
    <ref id="R33">
      <label>33</label>
      <element-citation publication-type="journal">
        <collab>UniProt-Consortium</collab>
        <article-title>UniProt: a hub for protein information</article-title>
        <source>Nucleic Acids Res</source>
        <volume>43</volume>
        <fpage>D204</fpage>
        <lpage>212</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">25348405</pub-id>
      </element-citation>
    </ref>
    <ref id="R34">
      <label>34</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hodis</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A landscape of driver mutations in melanoma</article-title>
        <source>Cell</source>
        <volume>150</volume>
        <fpage>251</fpage>
        <lpage>263</lpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22817889</pub-id>
      </element-citation>
    </ref>
    <ref id="R35">
      <label>35</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meyer</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>mutation3D: Cancer Gene Prediction Through Atomic Clustering of Coding
Variants in the Structural Proteome</article-title>
        <source>Hum Mutat</source>
        <volume>37</volume>
        <fpage>447</fpage>
        <lpage>456</lpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">26841357</pub-id>
      </element-citation>
    </ref>
    <ref id="R36">
      <label>36</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Adzhubei</surname>
            <given-names>IA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A method and server for predicting damaging missense
mutations</article-title>
        <source>Nat Methods</source>
        <volume>7</volume>
        <fpage>248</fpage>
        <lpage>249</lpage>
        <year>2010</year>
        <pub-id pub-id-type="pmid">20354512</pub-id>
      </element-citation>
    </ref>
    <ref id="R37">
      <label>37</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hopf</surname>
            <given-names>TA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mutation effects predicted from sequence co-variation</article-title>
        <source>Nat Biotechnol</source>
        <volume>35</volume>
        <fpage>128</fpage>
        <lpage>135</lpage>
        <year>2017</year>
        <pub-id pub-id-type="pmid">28092658</pub-id>
      </element-citation>
    </ref>
    <ref id="R38">
      <label>38</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>David</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Razali</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wass</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>Sternberg</surname>
            <given-names>MJ</given-names>
          </name>
        </person-group>
        <article-title>Protein-protein interaction sites are hot spots for disease-associated
nonsynonymous SNPs</article-title>
        <source>Hum Mutat</source>
        <volume>33</volume>
        <fpage>359</fpage>
        <lpage>363</lpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22072597</pub-id>
      </element-citation>
    </ref>
    <ref id="R39">
      <label>39</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>RN</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Bone Morphogenetic Protein (BMP) signaling in development and human
diseases</article-title>
        <source>Genes &amp; diseases</source>
        <volume>1</volume>
        <fpage>87</fpage>
        <lpage>105</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">25401122</pub-id>
      </element-citation>
    </ref>
    <ref id="R40">
      <label>40</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Roth</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SMAD genes in juvenile polyposis</article-title>
        <source>Genes, chromosomes &amp; cancer</source>
        <volume>26</volume>
        <fpage>54</fpage>
        <lpage>61</lpage>
        <year>1999</year>
        <pub-id pub-id-type="pmid">10441006</pub-id>
      </element-citation>
    </ref>
    <ref id="R41">
      <label>41</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ngeow</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Exome Sequencing Reveals Germline SMAD9 Mutation That Reduces Phosphatase
and Tensin Homolog Expression and Is Associated With Hamartomatous Polyposis and
Gastrointestinal Ganglioneuromas</article-title>
        <source>Gastroenterology</source>
        <volume>149</volume>
        <fpage>886</fpage>
        <lpage>889 e885</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">26122142</pub-id>
      </element-citation>
    </ref>
    <ref id="R42">
      <label>42</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maron</surname>
            <given-names>BJ</given-names>
          </name>
        </person-group>
        <article-title>Hypertrophic cardiomyopathy: a systematic review</article-title>
        <source>Jama</source>
        <volume>287</volume>
        <fpage>1308</fpage>
        <lpage>1320</lpage>
        <year>2002</year>
        <pub-id pub-id-type="pmid">11886323</pub-id>
      </element-citation>
    </ref>
    <ref id="R43">
      <label>43</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Donkervoort</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cardiomyopathy in patients with ACTA1-myopathy</article-title>
        <source>Abstracts/Neuromuscular Disorders</source>
        <volume>25</volume>
        <fpage>S184</fpage>
        <lpage>S316</lpage>
        <year>2015</year>
      </element-citation>
    </ref>
    <ref id="R44">
      <label>44</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sparrow</surname>
            <given-names>JC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Muscle disease caused by mutations in the skeletal muscle alpha-actin gene
(ACTA1)</article-title>
        <source>Neuromuscular disorders: NMD</source>
        <volume>13</volume>
        <fpage>519</fpage>
        <lpage>531</lpage>
        <year>2003</year>
        <pub-id pub-id-type="pmid">12921789</pub-id>
      </element-citation>
    </ref>
    <ref id="R45">
      <label>45</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lek</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Analysis of protein-coding genetic variation in 60,706
humans</article-title>
        <source>Nature</source>
        <volume>536</volume>
        <fpage>285</fpage>
        <lpage>291</lpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">27535533</pub-id>
      </element-citation>
    </ref>
    <ref id="R46">
      <label>46</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Forbes</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>COSMIC: mining complete cancer genomes in the Catalogue of Somatic
Mutations in Cancer</article-title>
        <source>Nucleic Acids Research</source>
        <volume>39</volume>
        <fpage>50</fpage>
        <year>2011</year>
      </element-citation>
    </ref>
    <ref id="R47">
      <label>47</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kandoth</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mutational landscape and significance across 12 major cancer
types</article-title>
        <source>Nature</source>
        <volume>502</volume>
        <fpage>333</fpage>
        <lpage>339</lpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">24132290</pub-id>
      </element-citation>
    </ref>
    <ref id="R48">
      <label>48</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lawrence</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mutational heterogeneity in cancer and the search for new cancer-associated
genes</article-title>
        <source>Nature</source>
        <volume>499</volume>
        <fpage>214</fpage>
        <lpage>218</lpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">23770567</pub-id>
      </element-citation>
    </ref>
    <ref id="R49">
      <label>49</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tasan</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Selecting causal genes from genome-wide association studies via
functionally coherent subnetworks</article-title>
        <source>Nat Methods</source>
        <volume>12</volume>
        <fpage>154</fpage>
        <lpage>159</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">25532137</pub-id>
      </element-citation>
    </ref>
    <ref id="R50">
      <label>50</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kamburov</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Comprehensive assessment of cancer missense mutation clustering in protein
structures</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of
America</source>
        <volume>112</volume>
        <fpage>E5486</fpage>
        <lpage>5495</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">26392535</pub-id>
      </element-citation>
    </ref>
    <ref id="R51">
      <label>51</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kucukkal</surname>
            <given-names>TG</given-names>
          </name>
          <name>
            <surname>Petukh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Alexov</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Structural and physico-chemical effects of disease and non-disease nsSNPs
on proteins</article-title>
        <source>Current opinion in structural biology</source>
        <volume>32</volume>
        <fpage>18</fpage>
        <lpage>24</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">25658850</pub-id>
      </element-citation>
    </ref>
    <ref id="R52">
      <label>52</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Petukh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Alexov</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Panchenko</surname>
            <given-names>AR</given-names>
          </name>
        </person-group>
        <article-title>Predicting the Impact of Missense Mutations on Protein-Protein Binding
Affinity</article-title>
        <source>J Chem Theory Comput</source>
        <volume>10</volume>
        <fpage>1770</fpage>
        <lpage>1780</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24803870</pub-id>
      </element-citation>
    </ref>
    <ref id="R53">
      <label>53</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lounnas</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Current progress in Structure-Based Rational Drug Design marks a new
mindset in drug discovery</article-title>
        <source>Computational and structural biotechnology journal</source>
        <volume>5</volume>
        <fpage>e201302011</fpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">24688704</pub-id>
      </element-citation>
    </ref>
    <ref id="R54">
      <label>54</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peng</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Obradovic</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Vucetic</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Exploring bias in the Protein Data Bank using contrast
classifiers</article-title>
        <source>Pac Symp Biocomput</source>
        <fpage>435</fpage>
        <lpage>446</lpage>
        <year>2004</year>
        <pub-id pub-id-type="pmid">14992523</pub-id>
      </element-citation>
    </ref>
    <ref id="R55">
      <label>55</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dunker</surname>
            <given-names>AK</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The unfoldomics decade: an update on intrinsically disordered
proteins</article-title>
        <source>BMC genomics</source>
        <volume>9</volume>
        <issue>Suppl 2</issue>
        <fpage>S1</fpage>
        <year>2008</year>
      </element-citation>
    </ref>
    <ref id="R56">
      <label>56</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Orchard</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Protein interaction data curation: the International Molecular Exchange
(IMEx) consortium</article-title>
        <source>Nat Methods</source>
        <volume>9</volume>
        <fpage>345</fpage>
        <lpage>350</lpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22453911</pub-id>
      </element-citation>
    </ref>
    <ref id="R57">
      <label>57</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Salwinski</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Database of Interacting Proteins: 2004 update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>32</volume>
        <fpage>D449</fpage>
        <lpage>451</lpage>
        <year>2004</year>
        <pub-id pub-id-type="pmid">14681454</pub-id>
      </element-citation>
    </ref>
    <ref id="R58">
      <label>58</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kerrien</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The IntAct molecular interaction database in 2012</article-title>
        <source>Nucleic Acids Res</source>
        <volume>40</volume>
        <fpage>D841</fpage>
        <lpage>846</lpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22121220</pub-id>
      </element-citation>
    </ref>
    <ref id="R59">
      <label>59</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Licata</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MINT, the molecular interaction database: 2012 update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>40</volume>
        <fpage>D857</fpage>
        <lpage>861</lpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22096227</pub-id>
      </element-citation>
    </ref>
    <ref id="R60">
      <label>60</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chatr-Aryamontri</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The BioGRID interaction database: 2015 update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>43</volume>
        <fpage>D470</fpage>
        <lpage>478</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">25428363</pub-id>
      </element-citation>
    </ref>
    <ref id="R61">
      <label>61</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Turner</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>iRefWeb: interactive analysis of consolidated protein interaction data and
their supporting evidence</article-title>
        <source>Database (Oxford)</source>
        <volume>2010</volume>
        <fpage>baq023</fpage>
        <year>2010</year>
        <pub-id pub-id-type="pmid">20940177</pub-id>
      </element-citation>
    </ref>
    <ref id="R62">
      <label>62</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Keshava Prasad</surname>
            <given-names>TS</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human Protein Reference Database--2009 update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>37</volume>
        <fpage>D767</fpage>
        <lpage>772</lpage>
        <year>2009</year>
        <pub-id pub-id-type="pmid">18988627</pub-id>
      </element-citation>
    </ref>
    <ref id="R63">
      <label>63</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mewes</surname>
            <given-names>HW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MIPS: curated databases and comprehensive secondary data resources in
2010</article-title>
        <source>Nucleic Acids Res</source>
        <volume>39</volume>
        <fpage>D220</fpage>
        <lpage>224</lpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21109531</pub-id>
      </element-citation>
    </ref>
    <ref id="R64">
      <label>64</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alfarano</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Biomolecular Interaction Network Database and related tools 2005
update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>33</volume>
        <fpage>D418</fpage>
        <lpage>424</lpage>
        <year>2005</year>
        <pub-id pub-id-type="pmid">15608229</pub-id>
      </element-citation>
    </ref>
    <ref id="R65">
      <label>65</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruepp</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CORUM: the comprehensive resource of mammalian protein
complexes--2009</article-title>
        <source>Nucleic Acids Res</source>
        <volume>38</volume>
        <fpage>D497</fpage>
        <lpage>501</lpage>
        <year>2010</year>
        <pub-id pub-id-type="pmid">19884131</pub-id>
      </element-citation>
    </ref>
    <ref id="R66">
      <label>66</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guldener</surname>
            <given-names>U</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MPact: the MIPS protein interaction resource on yeast</article-title>
        <source>Nucleic Acids Res</source>
        <volume>34</volume>
        <fpage>D436</fpage>
        <lpage>441</lpage>
        <year>2006</year>
        <pub-id pub-id-type="pmid">16381906</pub-id>
      </element-citation>
    </ref>
    <ref id="R67">
      <label>67</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brown</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Jurisica</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Online predicted human interaction database</article-title>
        <source>Bioinformatics</source>
        <volume>21</volume>
        <fpage>2076</fpage>
        <lpage>2082</lpage>
        <year>2005</year>
        <pub-id pub-id-type="pmid">15657099</pub-id>
      </element-citation>
    </ref>
    <ref id="R68">
      <label>68</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pagel</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The MIPS mammalian protein-protein interaction database</article-title>
        <source>Bioinformatics</source>
        <volume>21</volume>
        <fpage>832</fpage>
        <lpage>834</lpage>
        <year>2005</year>
        <pub-id pub-id-type="pmid">15531608</pub-id>
      </element-citation>
    </ref>
    <ref id="R69">
      <label>69</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hermjakob</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The HUPO PSI’s molecular interaction format--a community standard
for the representation of protein interaction data</article-title>
        <source>Nat Biotechnol</source>
        <volume>22</volume>
        <fpage>177</fpage>
        <lpage>183</lpage>
        <year>2004</year>
        <pub-id pub-id-type="pmid">14755292</pub-id>
      </element-citation>
    </ref>
    <ref id="R70">
      <label>70</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>HM</given-names>
          </name>
        </person-group>
        <article-title>The Protein Data Bank</article-title>
        <source>Nucleic Acids Research</source>
        <volume>28</volume>
        <year>2000</year>
      </element-citation>
    </ref>
    <ref id="R71">
      <label>71</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Velankar</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SIFTS: Structure Integration with Function, Taxonomy and Sequences
resource</article-title>
        <source>Nucleic Acids Research</source>
        <volume>41</volume>
        <fpage>9</fpage>
        <year>2013</year>
      </element-citation>
    </ref>
    <ref id="R72">
      <label>72</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Richards</surname>
            <given-names>FM</given-names>
          </name>
        </person-group>
        <article-title>The interpretation of protein structures: estimation of static
accessibility</article-title>
        <source>J Mol Biol</source>
        <volume>55</volume>
        <fpage>379</fpage>
        <lpage>400</lpage>
        <year>1971</year>
        <pub-id pub-id-type="pmid">5551392</pub-id>
      </element-citation>
    </ref>
    <ref id="R73">
      <label>73</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pedregosa</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Scikit-learn: Machine Learning in Python</article-title>
        <source>Journal of Machine Learning Research</source>
        <volume>12</volume>
        <fpage>2825</fpage>
        <lpage>2830</lpage>
        <year>2011</year>
      </element-citation>
    </ref>
    <ref id="R74">
      <label>74</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Breiman</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Random Forests</article-title>
        <source>Mach Learn</source>
        <volume>45</volume>
        <fpage>5</fpage>
        <lpage>32</lpage>
        <year>2001</year>
      </element-citation>
    </ref>
    <ref id="R75">
      <label>75</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Witten</surname>
            <given-names>IH</given-names>
          </name>
          <name>
            <surname>Frank</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Pal</surname>
            <given-names>CJ</given-names>
          </name>
        </person-group>
        <source>Data Mining: Practical Machine Learning Tools and Techniques</source>
        <publisher-name>Elsevier Science</publisher-name>
        <year>2016</year>
      </element-citation>
    </ref>
    <ref id="R76">
      <label>76</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Punta</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Pfam protein families database</article-title>
        <source>Nucleic Acids Res</source>
        <volume>40</volume>
        <fpage>D290</fpage>
        <lpage>301</lpage>
        <year>2012</year>
        <pub-id pub-id-type="pmid">22127870</pub-id>
      </element-citation>
    </ref>
    <ref id="R77">
      <label>77</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sørensen</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>A method of establishing groups of equal amplitude in plant sociology based
on similarity of species and its application to analyses of the vegetation on Danish
commons</article-title>
        <source>Biol Skr</source>
        <volume>5</volume>
        <fpage>1</fpage>
        <lpage>34</lpage>
        <year>1948</year>
      </element-citation>
    </ref>
    <ref id="R78">
      <label>78</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Henikoff</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Predicting the effects of coding non-synonymous variants on protein
function using the SIFT algorithm</article-title>
        <source>Nature protocols</source>
        <volume>4</volume>
        <fpage>1073</fpage>
        <lpage>1081</lpage>
        <year>2009</year>
        <pub-id pub-id-type="pmid">19561590</pub-id>
      </element-citation>
    </ref>
    <ref id="R79">
      <label>79</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tyner</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The UCSC Genome Browser database: 2017 update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>45</volume>
        <fpage>D626</fpage>
        <lpage>D634</lpage>
        <year>2017</year>
        <pub-id pub-id-type="pmid">27899642</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<floats-group>
  <fig id="F1" orientation="portrait" position="float">
    <label>Figure 1</label>
    <caption>
      <p>The current size of structural interactomes. (a) The plot shows the coverage (number of
protein interactions) of known high quality binary interactomes with pre-computed
co-complexed protein structures. (b) The number of interactions from the 8 largest
interactomes with experimentally solved structures.</p>
    </caption>
    <graphic xlink:href="nihms925038f1"/>
  </fig>
  <fig id="F2" orientation="portrait" position="float">
    <label>Figure 2</label>
    <caption>
      <p>ECLAIR prediction results. (a) Workflow for classifying interfaces for all interactions
in 8 species. Interactions without experimentally determined or homology modeled
interfaces are classified by ECLAIR. (b) ROC and precision-recall curves comparing ECLAIR
with the indicated interface residue prediction methods. (c) Fraction of interactions
disrupted by the introduction of random population variants in known and predicted
interfaces. (Significance determined by two-sided Z-test; <italic>n.s.</italic> denotes
not significant)</p>
    </caption>
    <graphic xlink:href="nihms925038f2"/>
  </fig>
  <fig id="F3" orientation="portrait" position="float">
    <label>Figure 3</label>
    <caption>
      <p>Workflow for calculating mutation and variant enrichment using Interactome INSIDER
(<ext-link ext-link-type="uri" xlink:href="http://interactomeinsider.yulab.org">http://interactomeinsider.yulab.org</ext-link>). Users may submit mutations or select
sets of known disease and cancer mutations to assess their enrichment in interface domains
and residues, or may compute 3D atomic clusters of mutations in proteins and across
interfaces.</p>
    </caption>
    <graphic xlink:href="nihms925038f3"/>
  </fig>
  <fig id="F4" orientation="portrait" position="float">
    <label>Figure 4</label>
    <caption>
      <p>Functional properties of predicted interfaces. (a) Enrichment of disease mutations in
predicted and known interfaces. In a–c, enrichment (log odds ratio) is the odds of
mutations and variants to appear in and outside of predicted and known interfaces compared
to the odds of any residues to exist in these categories. (b) Enrichment of recurrent
cancer mutations in predicted and known interfaces. (c) Enrichment of rare and common
population variants in predicted and known interfaces. (d, e) Predicted deleteriousness of
population variants in known and predicted interfaces using PolyPhen-2 (d) or EVmutation
(e). (In b, significance determined by two-sided Z-test. In d-e, significance determined
by a two-sided U-test. IRES=interface residues)</p>
    </caption>
    <graphic xlink:href="nihms925038f4"/>
  </fig>
  <fig id="F5" orientation="portrait" position="float">
    <label>Figure 5</label>
    <caption>
      <p>Interaction partner-specific interface prediction. (a) The top schematic depicts the
TGF-β/BMP signaling pathway. The bottom schematic illustrates that atomic
clustering reveals a mutation hotspot for juvenile polyposis syndrome at the interface of
SMAD8 and SMAD4. At right, yeast two-hybrid experiments test the interactions of one of
the SMAD4 mutations (Y353S) with SMAD8 and RASSF5. The mutation is not predicted by ECLAIR
to be at the SMAD4-RASS5 interface. (b) Superimposed docking results of two different
interaction partners with TK1. The differentially predicted interfaces of TK1 with each of
its partners correspond with the orientation of the docked poses. (c) The plot shows the
fraction of disease mutation pairs in known (blue) or predicted (orange) interfaces that
cause the same disease when mutations are within a given interaction interface compared to
when mutations are not within an interaction interface. (d) The plot shows the fraction of
disease mutation pairs in known (blue) or predicted (orange) interfaces that cause
different diseases when mutations are in the same interaction interface compared to in
different interaction interfaces (interaction with other proteins is not shown).
(Significance determined by two-sided Z-test)</p>
    </caption>
    <graphic xlink:href="nihms925038f5"/>
  </fig>
  <fig id="F6" orientation="portrait" position="float">
    <label>Figure 6</label>
    <caption>
      <p>The hypertrophic cardiomyopathy (HCM) pathway. The schematic on the left shows the
interaction of proteins in the HGM KEGG pathway (hsa04510). On the right is shown a
network of KEGG pathway proteins and their structurally-resolved interactions from
Interactome INSIDER. Proteins that harbor HCM mutations are colored in red. Interfaces are
noted for their enrichment of HCM mutations.</p>
    </caption>
    <graphic xlink:href="nihms925038f6"/>
  </fig>
</floats-group>
